Navigation Links
Amarin Prices Public Offering of American Depositary Shares
Date:1/6/2011

schull@russopartnersllc.commartina.schwarzkopf@russopartnersllc.comMark Swallow or David Dible Citigate Dewe Rogerson In U.K.: +44 (0)207 638 9571 mark.swallow@citigatedr.co.ukDisclosure NoticeThis press release contains forward-looking statements, within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements related to the Company's public offering of American Depositary Shares, are forward-looking statements that involve risks and uncertainties. Words such as "intends," "plans," "expects," "may," "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not promises or guarantees. These forward-looking statements are based upon the Company's current expectations. Actual events and results and the timing of events and results could differ materially from those anticipated in such forward-looking statements.  Among the factors that could cause actual results to differ materially from those described or projected herein are the following: risks related to the underwriters' consummation of their obligation to purchase the securities, whether the Company will be able to satisfy its obligations to close the offering and the risk that the Company will not use the proceeds from the offering in the manner contemplated, as well as the risks, uncertainties and other matters detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 20-F and the preliminary prospectus supplement relating to the offering and filed on January 5, 2011. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. The Company undertakes
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
2. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
3. Amarin to Present at UBS Life Sciences Conference
4. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
5. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
6. Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing
7. As Drug Prices Rise, Seniors are Advised to Review Their Medicare Prescription Coverage
8. Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market
9. Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015
10. NCPA: AARP Report Finds Brand Name Drug Prices Soar as Large Pharmacy Benefit Managers Reap Windfall Profits
11. Neurocrine Biosciences, Inc. Prices Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ...
(Date:1/15/2014)... to Millennium Research Group (MRG), the global authority ... United States and European transcatheter embolization ... through 2022, with embolization particles representing one of ... drug-eluting beads (DEBs) and radioembolization spheres in interventional ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today ... 2010.  Third quarter 2010 net revenues were $42.0 million, ... 2009.  Excluding the recognition of one-time license revenue in ... 44%.  Net loss for the third quarter ended September ...
... 2, 2010 Cannabis Science, Inc. (OTC Bulletin Board: ... cannabis products, is pleased to announce to its shareholders and ... decisions and processes regarding the new class of common shares. ... 1 for 10 new share dividend payment for shareholders of ...
Cached Medicine Technology:ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 2ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 3ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 4ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 5ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 6ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 7ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 8ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 9ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 10Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010 2Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010 3
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... has created a new technology for modifying human ... the body and selectively target cancer and other ... that monitor and modify human physiology is a ... existing technology enabled bioengineers to build such devices ... in a customized fashion. , "The project addressed ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit ... issues, published a comprehensive review today examining the current ... virus. The review calls for improved global surveillance strategies ... the recent outbreak of Ebola in West Africa that ... countries of Guinea and Liberia. According to the ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... Oct. 7 All American gymnast, wife and mom-to-be Shannon ... expecting her first baby in late October and has been ... best possible start on life and learning. Now she,s ... moms around the world. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091007/DE88885 ...
... suspect , WEDNESDAY, Oct. 7 (HealthDay News) -- Younger people ... an anterior cruciate ligament repaired, a new study has ... commonly called an ACL. , ACL damage is one of ... data from more than 70,000 people in New York who ...
... those with, without device , WEDNESDAY, Oct. 7 (HealthDay News) ... heart attack does not improve survival, a major European study ... those given the devices, which shock the heart into beating ... as for those who did not get defibrillators in the ...
... Global TV Concepts, manufacturer and creator of the ... World Record title for the ,World,s Largest Cupcake., Weighing ... feet tall and six feet wide, the massive cupcake was ... from slices of the confectionary masterpiece supported breast cancer charities. ...
... Company,s (NYSE: CRDA ; CRDB) European third party ... name of Broadspire, a Crawford company, continuing the leading ... CRDA ; CRDB), the world,s largest independent provider ... the Broadspire brand at the Federation of European Risk ...
... US Farms, Inc. (Pink Sheets: USFM) today announced that it ... ( www.edisastersystems.com ) based out of City of ... , Yan Skwara, CEO for US Farms, Inc. ... and soothing burns and having our Aloe365(TM) Skin Gel registered ...
Cached Medicine News:Health News:Country's Most Decorated Gymnast New Spokesmom for BabyPlus 2Health News:2nd Knee Surgery Common Among Young Patients 2Health News:Early Defibrillator After Heart Attack May Not Pay Off 2Health News:Early Defibrillator After Heart Attack May Not Pay Off 3Health News:Big Top Cupcake(TM) Brand Awarded With Guinness World Record For World's Largest Cupcake 2Health News:Crawford & Company's Broadspire Unit Continues Its European Expansion 2Health News:US Farms, Inc. Becomes a Registered Seller of Its Aloe365(TM) Skin Gel With Emergency Disaster Systems, Inc. 2Health News:US Farms, Inc. Becomes a Registered Seller of Its Aloe365(TM) Skin Gel With Emergency Disaster Systems, Inc. 3Health News:US Farms, Inc. Becomes a Registered Seller of Its Aloe365(TM) Skin Gel With Emergency Disaster Systems, Inc. 4
Skin Tone External Eyelid Weights...
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
Zone Quick is a simple and accurate system that measures tear volume in just 15 seconds per eye. Each box has an easy to read diagnostic indicator rule....
... Stent has been introduced by FCI Ophthalmics, Inc. ... Lacrimal Stent addressed the limitations previously encountered with ... DCR. Brought in to position through the nose, ... is no need to pass the very large ...
Medicine Products: